More NewsRead More
Cutispharma, Dr. Reddy's Laboratories Announce Partnership
April 05, 2016
from PR Newswire
Dr. Reddy’s Laboratories Announces the Appointment of Mr. Bharat Doshi as an Additional Independent Director on the Board of the Company
May 11, 2016
Eisai Transfer the Rights to Investigational Anticancer Agent E7777 for European, U.S and Certain Emerging Markets to Dr. Reddy's Laboratories
March 31, 2016
from ACN Newswire
Dr. Reddy's to Release Q4 and Full Year FY16 Results on May 12, 2016; Earnings Call Slated for May 12, 6.30 PM IST / 9.00 AM EDT
April 26, 2016
ZEMBRACE™ SymTouch™ (Sumatriptan Injection) 3 mg, Approved by the FDA in January 2016 for the Acute Treatment of Migraine with or without Aura in Adults, is Now Commercially Available in the U.S.
April 19, 2016
The Market In 5 Minutes: Bold Moves
May 25, 2016
Technical Movement Driving Equities -- Research on RPC, Dr. Reddy's Laboratories, Nippon Telegraph And Telephone and Laclede Group
March 04, 2016
category Business & Professional Services
Dr. Reddy’s Laboratories Acquires the Rights to Investigational Anticancer Agent E7777 for U.S., Europe and Certain Emerging Markets from Eisai
March 31, 2016
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here